Inflammatory biomarkers in HIV-infected children hospitalized for severe malnutrition in Uganda and Zimbabwe.


Journal

AIDS (London, England)
ISSN: 1473-5571
Titre abrégé: AIDS
Pays: England
ID NLM: 8710219

Informations de publication

Date de publication:
15 07 2019
Historique:
pubmed: 23 4 2019
medline: 24 7 2020
entrez: 23 4 2019
Statut: ppublish

Résumé

A proportion of HIV-infected children with advanced disease develop severe malnutrition soon after antiretroviral therapy (ART) initiation. We tested the hypothesis that systemic inflammation underlies the pathogenesis of severe malnutrition in HIV-infected children. Cross-sectional laboratory substudy in 613 HIV-infected children initiating ART in Uganda and Zimbabwe. We measured C-reactive protein (CRP), TNFα, IL-6 and soluble CD14 by ELISA in cryopreserved plasma at baseline (pre-ART) and week-4 (children with severe malnutrition only). Independent associations between baseline biomarkers and subsequent hospitalization for severe malnutrition were identified using multivariable fractional polynomial logistic regression. Compared with children without severe malnutrition (n = 574, median age 6.3 years, median baseline weight-for-age Z-score -2.2), children hospitalized for severe malnutrition post-ART (n = 39, median age 2.3 years, median baseline weight-for-age Z-score -4.8) had higher baseline CRP [median 13.5 (interquartile range 5.5, 41.1) versus 4.1 (1.4, 14.4) mg/l; P = 0.003] and IL-6 [median 9.2 (6.7, 15.6) versus 5.9 (4.6, 9.3) pg/ml; P < 0.0001], but similar overall TNFα, soluble CD14 and HIV viral load (all P > 0.06). In a multivariable model, higher pre-ART IL-6, lower TNFα and lower weight-for-age were independently associated with subsequent hospitalization for severe malnutrition. Between weeks 0 and 4, there was a significant rise in CRP, IL-6 and soluble CD14, and fall in TNFα and HIV viral load in children hospitalized for severe malnutrition (all P < 0.02). Pre-ART IL-6 and TNFα were more strongly associated with hospitalization for severe malnutrition than CD4 cell count or viral load, highlighting the importance of inflammation at the time of ART initiation in HIV-infected children.

Identifiants

pubmed: 31008797
doi: 10.1097/QAD.0000000000002231
doi:

Substances chimiques

Biomarkers 0
Immunologic Factors 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1485-1490

Subventions

Organisme : Medical Research Council
ID : G1001190
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12023/17
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12023/26
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_EX_G0300400
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_U122886353
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 108065/Z/15/Z
Pays : United Kingdom

Auteurs

Andrew J Prendergast (AJ)

MRC Clinical Trials Unit at UCL.
Blizard Institute, Queen Mary University of London, London, UK.

Chipo Berejena (C)

University of Zimbabwe, Harare, Zimbabwe.

Godfrey Pimundu (G)

Joint Clinical Research Centre.

Annie Shonhai (A)

University of Zimbabwe, Harare, Zimbabwe.

Mutsa Bwakura-Dangarembizi (M)

University of Zimbabwe, Harare, Zimbabwe.

Victor Musiime (V)

Joint Clinical Research Centre.
College of Health Sciences, Makerere University, Kampala.

Alexander J Szubert (AJ)

MRC Clinical Trials Unit at UCL.

Adrian D Cook (AD)

MRC Clinical Trials Unit at UCL.

Moira J Spyer (MJ)

MRC Clinical Trials Unit at UCL.

Patricia Nahirya-Ntege (P)

MRC/UVRI Uganda Research Unit on AIDS, Entebbe.

Adeodata Kekitiinwa (A)

Baylor-Uganda, Mulago Hospital, Kampala, Uganda.

Diana M Gibb (DM)

MRC Clinical Trials Unit at UCL.

Nigel Klein (N)

UCL Great Ormond Street Institute of Child Health, London, UK.

A Sarah Walker (AS)

MRC Clinical Trials Unit at UCL.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH